English
 ． 中文

Investors

Adimmune Corporation is a publicly traded company on the Taiwan Stock Exchange (TWSE)

overview

Financial Information

2024

  • Q2 IFRSs Consolidated Financial Statements

  • Q2 IFRSs Consolidated Financial Statements

2023

  • Q1 IFRSs Consolidated Financial Statements

  • Q2 IFRSs Consolidated Financial Statements

  • Q3 IFRSs Consolidated Financial Statements

2022

  • Q1 IFRSs Consolidated Financial Statements

  • Q2 IFRSs Consolidated Financial Statements

  • Q3 IFRSs Consolidated Financial Statements

  • 2022 ADIMMUNE CONSOLIDATED FINANCIAL STATEMENT

  • 2022 ADIMMUNE PARENT COMPANY ONLY FINANCIAL STATEMENTS

2021

  • Q1 IFRSs Consolidated Financial Statements

  • Q2 IFRSs Consolidated Financial Statements

  • Q3 IFRSs Consolidated Financial Statements

  • 2021 ADIMMUNE CONSOLIDATED FINANCIAL STATEMENTS

  • 2021 ADIMMUNE PARENT COMPANY ONLY FINANCIAL STATEMENTS